Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
Rahul Kumar, Boon-Bee George Goh, Jia-Wen Kam, Pik-Eu Chang, Chee-Kiat Tan
Clin Mol Hepatol. 2020;26(2):196-208.   Published online 2020 Jan 9     DOI: https://doi.org/10.3350/cmh.2019.0012
Citations to this article as recorded by Crossref logo
Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies
Yusra Zarlashat, Hassan Mushtaq, Linh Pham, Wasim Abbas, Keisaku Sato
International Journal of Molecular Sciences.2024; 25(13): 6830.     CrossRef
Association of modifiable metabolic risk factors and lifestyle with all-cause mortality in patients with hepatocellular carcinoma
Hwi Young Kim, Hye Ah Lee, Pompilia Radu, Jean-François Dufour
Scientific Reports.2024;[Epub]     CrossRef
Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis
Harry Crane, Guy D. Eslick, Cameron Gofton, Anjiya Shaikh, George Cholankeril, Mark Cheah, Jian-Hong Zhong, Gianluca Svegliati-Baroni, Alessandro Vitale, Beom Kyung Kim, Sang Hoon Ahn, Mi Na Kim, Simone I Strasser, Jacob George
Clinical and Molecular Hepatology.2024; 30(3): 436.     CrossRef
The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clinical and Molecular Hepatology.2023; 29(1): 99.     CrossRef
Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
Seung Min Lee, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(1): 171.     CrossRef
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians
Annalisa Cespiati, Felice Cinque, Marica Meroni, Rosa Lombardi, Paola Dongiovanni, Anna Ludovica Fracanzani
Biomedicines.2023; 11(2): 586.     CrossRef
Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
Yi-Te Lee, Mohammad A. Karim, Hye Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
Clinical and Molecular Hepatology.2023; 29(2): 453.     CrossRef
Exploration of the potential mechanism of the Fuzheng Xiegan decoction for treating hepatocellular carcinoma based on experimental and network pharmacological analyses
Menghan Wang, Ni Zheng, Zhongchao Mai, Borong Zhou, Xinlin Yang, Miao Zhang, Wei Xia, Ying Ye
European Journal of Integrative Medicine.2023; 60: 102257.     CrossRef
Association Between Nutrient Patterns and Fatty Liver Index: Baseline Survey of the Japan Multi-Institutional Collaborative Cohort Study in Tokushima, Japan
Nguyen Van Tien, Kokichi Arisawa, Hirokazu Uemura, Nahomi Imaeda, Chiho Goto, Sakurako Katsuura-Kamano
Journal of Epidemiology.2022; 32(8): 376.     CrossRef
Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study
Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, Wattana Sukeepaisarnjaroen, Juan Ignacio Esteban, Marta Bes, Bruno Köhler, Ying He, Magdalena Swiatek‐de Lange, David Morgenstern, Henry Lik‐Yuen Chan
Hepatology Communications.2022; 6(4): 679.     CrossRef
The Burden of Nonalcoholic Steatohepatitis: A Systematic Review of Epidemiology Studies
Elliot B. Tapper, Charlotte Fleming, Adriana Rendon, João Fernandes, Pierre Johansen, Margarida Augusto, Sunita Nair
Gastro Hep Advances.2022; 1(6): 1049.     CrossRef
Herbal Medicine-derived Compounds for the Prevention and Treatment of Hepatocellular Carcinoma
Zahra Farzaneh, Maryam Farzaneh
Current Cancer Therapy Reviews.2022; 18(4): 230.     CrossRef
Prognosis after Hepatic Resection of Patients with Hepatocellular Carcinoma Related to NAFLD or MAFLD: A Systematic Review and Meta-Analysis
Zhujian Deng, Jiayong Su, Yuxian Teng, Si Xie, Rongrui Huo, Chaojing Chen, Liang Ma, Jianhong Zhong
SSRN Electronic Journal.2022;[Epub]     CrossRef
Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma
Hwi Young Kim, Jean-François Dufour
Clinical and Molecular Hepatology.2020; 26(2): 238.     CrossRef
Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
Ju Hyun Shim
Clinical and Molecular Hepatology.2020; 26(2): 183.     CrossRef
From intestinal dysbiosis to alcohol-associated liver disease
Beatriz Garcia Mendes, Bernd Schnabl
Clinical and Molecular Hepatology.2020; 26(4): 595.     CrossRef
Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Gi Soo Youn, Tae Suk Kim, Baek Gyu Jun, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Dong Joon Kim, Soon Koo Baik, Dae Hee Choi, Ki Tae Suk
Cancers.2020; 12(11): 3347.     CrossRef